ramatroban

DRUG2 trials

Sponsors

Research Center Borstel, KARE Biosciences

Conditions

AsthmaCOVID-19 PneumoniaCOVID-19 Respiratory Infection

Phase 2

Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite

WithdrawnNCT00311051

Research Center BorstelAsthma

Start: 2005-04-30End: 2007-04-30Updated: 2012-04-16

Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

RecruitingNCT05706454

KARE BiosciencesCOVID-19 Pneumonia, COVID-19 Respiratory Infection

Start: 2022-11-10End: 2026-05-31Target: 324Updated: 2023-01-31